Lowe Brockenbrough & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Hold
1,000
0.01% 259
2026
Q1
$267K Hold
1,000
0.01% 255
2025
Q4
$251K Hold
1,000
0.01% 264
2025
Q3
$287K Hold
1,000
0.01% 260
2025
Q2
$263K Hold
1,000
0.01% 255
2025
Q1
$233K Hold
1,000
0.02% 256
2024
Q4
$229K Hold
1,000
0.01% 256
2024
Q3
$223K Hold
1,000
0.01% 258
2024
Q2
$204K Hold
1,000
0.01% 256
2024
Q1
$218K Hold
1,000
0.01% 255
2023
Q4
$227K Hold
1,000
0.02% 250
2023
Q3
$201K Sell
1,000
-513
-34% -$108K 0.02% 260
2023
Q2
$314K Hold
1,513
0.02% 241
2023
Q1
$298K Buy
+1,513
New +$311K 0.02% 237
2022
Q3
Sell
-1,048
Closed -$211K 256
2022
Q2
$211K Hold
1,048
0.02% 255
2022
Q1
$237K Sell
1,048
-248
-19% -$58.3K 0.02% 258
2021
Q4
$350K Hold
1,296
0.03% 218
2021
Q3
$313K Buy
+1,296
New +$327K 0.02% 242

Other funds holding LH

Lowe Brockenbrough & Co's LH Position: Q2 2026 in Review

Lowe Brockenbrough & Co held its Labcorp (LH) position steady in Q2 2026 at 1,000 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #259.

Lowe Brockenbrough & Co first reported a position in LH in Q3 2021 and has held it in 18 quarters since. The position peaked at $350K in Q4 2021. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Lowe Brockenbrough & Co held 1,000 shares of Labcorp worth $280K as of Q2 2026.
  • Lowe Brockenbrough & Co left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.01% of Lowe Brockenbrough & Co's portfolio in Q2 2026, its #259 holding.
  • Lowe Brockenbrough & Co first reported a position in Labcorp in Q3 2021 and has held it in 18 quarters since.
  • Lowe Brockenbrough & Co's Labcorp position peaked at $350K in Q4 2021.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q2 2026, filed 3 Aug 2026.